Deactivation of cisplatin-resistant human lung/ovary cancer cells with pyropheophorbide-α methyl ester-photodynamic therapy. Issue 12 (2nd December 2017)

• Record Type: Journal Article
• Authors: Qian, Guanhua; Wang, Li; Zheng, Xueling; Yu, Tinghe
• Is Part Of: Cancer biology & therapy. Volume 18:Issue 12(2017)
• Page Start: 984
• Page End: 989
• Publication Date: 2017-12-02
• Subjects: cisplatin resistance -- photodynamic therapy -- pyropheophorbide-α methyl ester -- reactive oxygen species; 616.99406
• DOI: 10.1080/15384047.2017.1385683
• Languages: English
• ISSNs: 1538-4047

Abstract

Abstract: The aim of this study was to determine whether photodynamic therapy (PDT) alone or combined with cisplatin (DDP), can deactivate cisplatin-resistant cancer cells. Human cancer cell lines A549 and SKOV3, and chemoresistant sublines A549/DDP and SKOV3/DDP, were subjected to PDT, DDP, or PDT combined with DDP. Cell viability and apoptosis were analyzed, and then intracellular reactive oxygen species (ROS) and proteins related to apoptosis were determined. PDT caused cell death, and PDT combined with DDP led to the highest percentage of dead cells in 4 cell lines; similar results were detected in ROS; a quantification evaluation manifested that the combined effect was addition. DDP increased the percentage of apoptotic cells, and the ROS level in A549 and SKOV3 cells, which was not observed in A549/DDP and SKOV3/DDP cells. Western blot revealed an increase of caspase 3 and Bax, and a decrease of Bcl-2, demonstrating the occurrence of apoptosis. The data suggest that PDT can efficiently deactivate resistant cells and enhance the action of DDP against resistant cancer cells.